With over 200 biosimilars approved globally (1) and many top-selling biologics losing exclusivity in the next five years, the demand for cost-efficient, large-scale production of recombinant antibody therapeutics is growing.
Signal peptides – a significantly underutilized element in protein engineering
Despite existing in hundreds of thousands and expressing significant diversity, signal peptides have largely remained unexplored in commercial protein engineering. This is a missed opportunity as almost all therapeutic proteins and mRNA therapies contain a signal peptide that can be engineered for optimized production and functionality.
Meet us at PEGS Europe 2024
PEGS Europe, a biologics technology conference will be held in Barcelona, on November 5-7. Join our talk on November 6 by CEO Tero-Pekka Alastalo on optimizing protein expression with signal peptides.